Related Experiment Video

Updated: Apr 21, 2026

Profiling Voltage-gated Potassium Channel mRNA Expression in Nigral Neurons using Single-cell RT-PCR Techniques
07:31

Profiling Voltage-gated Potassium Channel mRNA Expression in Nigral Neurons using Single-cell RT-PCR Techniques

Published on: September 27, 2011

14.6K

Potassium channel Kv1.3 is highly expressed by microglia in human Alzheimer's disease

Srikant Rangaraju1, Marla Gearing1, Lee-Way Jin2

  • 1Department of Neurology, Emory University, Atlanta, GA, USA.

Journal of Alzheimer'S Disease : JAD
|November 2, 2014
PubMed

Insights

Alzheimer's disease (AD) involves neuroinflammation orchestrated by microglia. This study found increased Kv1.3 potassium channels in AD brain microglia, suggesting Kv1.3 as a potential therapeutic target for Alzheimer's disease.

Area of Science:

  • Neuroscience
  • Immunology
  • Genetics

Background:

  • Alzheimer's disease (AD) pathogenesis involves neuroinflammation orchestrated by microglia.
  • Kv1.3 potassium channels are implicated in microglial activation and inflammatory responses in vitro.
  • Therapeutic targeting of Kv1.3 is relevant in autoimmune diseases.

Purpose of the Study:

  • To investigate if Kv1.3 channel expression is elevated in human Alzheimer's disease brain tissue.
  • To determine if Kv1.3 channels are specifically localized to microglia in AD brains.

Main Methods:

  • Postmortem immunohistochemical analysis of frontal cortex from AD patients and controls.
  • Semi-quantitative assessment of Kv1.3 staining intensity and cell density.
  • Immunofluorescence co-localization studies with microglial (Iba1) and astrocyte (GFAP) markers.
  • Western blot analysis to confirm protein expression levels.

Main Results:

  • Significantly higher Kv1.3 staining intensity and positive cell density were observed in AD brains compared to controls (p = 0.03).
  • Increased numbers of Iba1-positive microglia were found in AD brains.
  • Kv1.3 expression was confirmed to be microglia-specific, co-localizing with Iba1 and not GFAP.
  • Western blot analysis corroborated increased Kv1.3 expression in AD brains.

Conclusions:

  • Kv1.3 channels are upregulated in microglia within the human Alzheimer's disease brain.
  • Elevated Kv1.3 expression in microglia is associated with AD neuropathology.
  • Kv1.3 channels represent a biologically relevant, microglia-specific therapeutic target for Alzheimer's disease.
Keywords:
Alzheimer's diseaseKv1.3microglianeuroinflammationpotassium channel

More Related Videos

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes11:33

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes

Published on: March 12, 2013

12.7K
Making, Testing, and Using Potassium Ion Selective Microelectrodes in Tissue Slices of Adult Brain11:20

Making, Testing, and Using Potassium Ion Selective Microelectrodes in Tissue Slices of Adult Brain

Published on: May 7, 2018

11.9K

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
7
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
7
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
11.1K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.5K